BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Dubai
BEGIN:STANDARD
TZOFFSETFROM:+0400
TZOFFSETTO:+0400
TZNAME:+04
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20220313T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20221106T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230720T130000
DTEND;TZID=UTC:20230720T173000
DTSTAMP:20260410T014722
CREATED:20230613T214002Z
LAST-MODIFIED:20230613T214002Z
UID:25234-1689858000-1689874200@scienceinboston.com
SUMMARY:2023 MassBio Diversity\, Equity\, and Inclusion Conference
DESCRIPTION:This year’s MassBio Diversity Equity and Inclusion (DEI) Conference will shine a light on the topic of health equity and how clinical trial diversity is a meaningful and achievable step toward the equitable delivery of health care. \nKeynote speakers and panelists will examine aspects of health equity including attaining trial diversity\, selecting diverse suppliers\, and earning patient and community trust. Participants will also leave with actionable takeaways and extensive resources after breaking into small groups for an interactive workshop. There will be ample time for participants to expand their networks\, share personal experiences\, and build the relationships that will lead to progress toward mutual DEI goals.
URL:https://scienceinboston.com/event/2023-massbio-diversity-equity-and-inclusion-conference/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20230720T130000
DTEND;TZID=Asia/Dubai:20230720T140000
DTSTAMP:20260410T014722
CREATED:20230717T173613Z
LAST-MODIFIED:20230717T173613Z
UID:25659-1689858000-1689861600@scienceinboston.com
SUMMARY:FSHD University – Epic Bio’s FSHD Program
DESCRIPTION:Epic Bio\, a San Francisco based therapeutics company\, is developing a gene therapy medicine specifically for FSHD patients. The new product\, termed EPI-321\, leverages a CRISPR-based platform to precisely find and fix the specific issue in the genome that causes FSHD. It works by restoring a process called methylation to repair the root cause of the disease without altering the DNA sequence. EPI-321 is an AAV-based gene therapy product delivered one time via intravenous infusion.
URL:https://scienceinboston.com/event/fshd-university-epic-bios-fshd-program/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230719T160000
DTEND;TZID=UTC:20230719T180000
DTSTAMP:20260410T014722
CREATED:20230613T214455Z
LAST-MODIFIED:20230613T214455Z
UID:25261-1689782400-1689789600@scienceinboston.com
SUMMARY:Christmas in July — MassBioHub Open House
DESCRIPTION:Celebrate Christmas in July at our MassBioHub Open House Reception! Join us as we transform our space into a winter wonderland\, complete with holiday decor\, music\, delectable food\, and refreshing drinks to showcase how the Hub is the perfect place for your upcoming 2023 holiday party. Throughout the reception\, we will be offering guided tours\, allowing you to explore the entire facility and discover its various room configurations. Come check out our offerings and see for yourself what everyone has been raving about! \nABOUT THE HUB\nThe MassBioHub is our state-of-the-art conference and business center located in the heart of Kendall Square in Cambridge\, MA. The Hub is an exclusive benefit for MassBio members\, and we offer this exceptional space at below-market rates. Whether you’re planning a small gathering or a larger event\, the MassBioHub can accommodate in-person groups of 2 to 150 individuals. Additionally\, we provide the option to host hybrid or virtual events\, ensuring flexibility to meet your unique needs. For more information and to view our packages\, visit massbio.org/hub.
URL:https://scienceinboston.com/event/christmas-in-july-massbiohub-open-house/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20230713T090000
DTEND;TZID=America/Halifax:20230716T180000
DTSTAMP:20260410T014722
CREATED:20230630T003440Z
LAST-MODIFIED:20230630T003440Z
UID:25494-1689238800-1689530400@scienceinboston.com
SUMMARY:The Protein Society 37th Annual Symposium
DESCRIPTION:Connect and share your ideas with hundreds of protein science professionals from around the globe. In addition to our dynamic program\, the Symposium will feature numerous networking and career-building opportunities\, as well as thematic workshops. Take advantage of discounted registration until May 31\, 2023. \nExplore your scientific interests and specialties with sessions in 12 specialty tracks and eight award-winning talks designed just for you. Check out our networking opportunities and DEI-focused events to be announced in the spring. Be sure to submit your abstract and apply for a Contributed\, Young Investigator Talk and/or Flash Talks included in every session.
URL:https://scienceinboston.com/event/the-protein-society-37th-annual-symposium/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Dubai:20230711T090000
DTEND;TZID=Asia/Dubai:20230713T180000
DTSTAMP:20260410T014722
CREATED:20230623T223525Z
LAST-MODIFIED:20230623T223525Z
UID:25422-1689066000-1689271200@scienceinboston.com
SUMMARY:4th RNA Editing Summit
DESCRIPTION:The 4th RNA Editing Summit returns as the first and only industry-dedicated forum solely focused on the research and therapeutic potential of RNA editing. \nOur 2023 event will welcome first disclosures of exciting data with important learnings being communicated so the field can advance toward the clinic. Expect exclusive data from KOLs on the most recent developments in ADAR\, APOBEC\, CRISPR-Cas13\, Cas7-11\, and exon editing. Join 80+ thought leaders from the likes of Wave Life Sciences\, ProQR\, Shape Therapeutics and Korro Bio to stay ahead of the curve and tap into the therapeutic potential of RNA editing and accelerate clinical validation. \nBringing together a new group of RNA editing senior decision makers\, a brand new 6-hour workshop day will delve into the key challenges facing RNA editing\, including delivery\, manufacturing and proof-of-concept.
URL:https://scienceinboston.com/event/the-protein-society-tps-37th-annual-symposium/
LOCATION:Hilton Boston Logan Airport\, One Hotel Drive\, Boston\, 02128\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230710T080000
DTEND;TZID=America/Vancouver:20230710T100000
DTSTAMP:20260410T014722
CREATED:20230613T214154Z
LAST-MODIFIED:20230613T214154Z
UID:25246-1688976000-1688983200@scienceinboston.com
SUMMARY:Shifting Your Mentality From Discovery to Development
DESCRIPTION:You’ve successfully taken the risks and done the research to turn your abstract thought into something physically real! \nAs Robert Redford’s character famously said at the end of The Candidate: “What do we do now?” Transitioning from research to development is the goal of every biotech company\, but there are also many common misunderstandings and misconceptions about what this shift entails. The costs (it’s expensive) and timelines (it takes a long time)\, onboarding new team members\, successfully doing both the R and the D at the same time\, and regulatory aspects of the change are among the things that must be understood and executed. \nApproaching this topic through the lens of today’s difficult funding environment and longer time horizons\, panelists will bring a breadth of experiences to detail best practices\, answer common (and uncommon) questions\, cover anticipated business challenges\, and likely tell a few horror stories.
URL:https://scienceinboston.com/event/shifting-your-mentality-from-discovery-to-development/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230627T160000
DTEND;TZID=UTC:20230627T203000
DTSTAMP:20260410T014722
CREATED:20230613T214417Z
LAST-MODIFIED:20230613T214417Z
UID:25256-1687881600-1687897800@scienceinboston.com
SUMMARY:MERIT Symposium at MassBio
DESCRIPTION:Join us at the MassBio Hub in Cambridge on June 27th for an oncology-focused networking and educational event hosted by MERIT. There will be great food and drinks provided along with insightful presentations by industry experts. Don’t miss Dr. Jan Cerny’s\, MD\, PhD\, FACP\, talk at 4:30 pm on how pandemic shifts have shaped hematological oncology trials going forward. Dr. Jimmy Belotte\, MD\, PhD\, FACOG\, will also be speaking at 5:15 pm to address the opportunities and challenges for diversity in clinical trials. This will be a key opportunity to network with industry peers and oncology KOLs.
URL:https://scienceinboston.com/event/merit-symposium-at-massbio/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230626T080000
DTEND;TZID=UTC:20230626T100000
DTSTAMP:20260410T014722
CREATED:20230613T214058Z
LAST-MODIFIED:20230613T214058Z
UID:25240-1687766400-1687773600@scienceinboston.com
SUMMARY:The Investment Climate’s Impact on Biotechs\, Tech Transfer & Pipeline
DESCRIPTION:Private biotechs are operating in a fundraising environment where access to capital is limited. This has led to a spike in shutdowns\, restructurings\, reductions-in-force\, and “strategic alternatives” across the industry that one VC investor recently cited. Smaller and more emerging companies may be wondering how to respond\, what nontraditional cash\, partnering\, and business opportunities exist\, and how to continue to access funding. For example\, “Should we extend our series A or go for a series B?” The market downturn is likewise impacting tech transfer\, company spin-out\, and the drug discovery pipeline. \nWhere are innovation and company creation pausing due to tight cash flows and cautious investors? Listen to a panel of speakers who can comment on these questions and offer insights from investor\, university\, and biotech perspectives.
URL:https://scienceinboston.com/event/the-investment-climates-impact-on-biotechs-tech-transfer-pipeline/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230623T090000
DTEND;TZID=America/Vancouver:20230623T170000
DTSTAMP:20260410T014722
CREATED:20230612T162537Z
LAST-MODIFIED:20230612T162537Z
UID:25199-1687510800-1687539600@scienceinboston.com
SUMMARY:Koch Institute Symposium 2023: Cancer Vaccines
DESCRIPTION:The symposium will feature a keynote talk from Federica Sallusto who is an expert in the field of human cellular immunology. \nThere will be two sessions which will include renown speakers from academia and industry including Michal Bassani-Sternberg\, Tyler Jacks\, Charles Swanton\, Olivera Finn\, Stefani Spranger and Pete DeMuth. \nAnd\, we have a special panel discussion with Bob Langer\, Paul Burton and Cathy Wu where they will discuss the impact of a vaccine in treatment and progression. \n 
URL:https://scienceinboston.com/event/koch-institute-symposium-2023-cancer-vaccines/
LOCATION:MA
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2023/06/https___cdn.evbuc_.com_images_463134559_87946005641_1_original.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230622T173000
DTEND;TZID=America/Vancouver:20230622T183000
DTSTAMP:20260410T014722
CREATED:20230613T213807Z
LAST-MODIFIED:20230613T213807Z
UID:25227-1687455000-1687458600@scienceinboston.com
SUMMARY:AWIS Boston: DEI Committee Kick-off Social
DESCRIPTION:The AWIS Boston Diversity\, Equity & Inclusion Committee invites you to join us for an outdoor social to kick-off our committee and to celebrate Pride Month. We’ll have food\, prizes\, celebration\, and discussion. Everyone is invited to join us whether or not you want to join the committee. We’ll provide some eats and dessert but feel free to bring something to share!
URL:https://scienceinboston.com/event/awis-boston-dei-committee-kick-off-social/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230621T143000
DTEND;TZID=America/Vancouver:20230621T180000
DTSTAMP:20260410T014722
CREATED:20230613T214256Z
LAST-MODIFIED:20230613T214256Z
UID:25252-1687357800-1687370400@scienceinboston.com
SUMMARY:Unveiling the Power Within: Tumoroids for Translational IO Drug Discovery & Development
DESCRIPTION:Join Nilogen on June 21st from 3:00-6:00pm at the MassBio HUB for an event dedicated to the importance of the tumor microenvironment in translational drug discovery and development. The event will feature a two part plenary session with a presentation session and panel discussion\, followed by a networking reception featuring cocktails and hors d’oeuvres. \nAgenda:\n2:30-3:00pm: Registration & Networking \n3:00-3:05pm: Introduction \n3:05-3:35pm: Plenary Presentation: “Tumoroids for Translational Drug Discovery & Development”\nPresenter: Dr. Soner Altiok\, M.D. PhD\, Founder & CSO\, Nilogen Oncosystems \n3:35-4:20pm: Panel Discussion: “Challenges in IO Drug Discovery\, Development\, and Clinical Translation”\nModerator: Rikhia Chakraborty PhD\, VP\, R&D & Operations\, Nilogen Oncosystems\nPanelists: \n\nJohanna Kaufmann PhD\, EVP Oncology\, Codagenix\nShilpa Demes PhD\, Director\, Translational Science\, Astellas Pharma\nKhalid Shah M.S. PhD\, Vice Chairman of Research\, Neurosurgery\, Brigham & Women’s Hospital\nSoner Altiok M.D. PhD\, Founder & CSO\, Nilogen Oncosystems\n\n4:20-6:00pm: Networking Reception
URL:https://scienceinboston.com/event/unveiling-the-power-within-tumoroids-for-translational-io-drug-discovery-development/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230620T080000
DTEND;TZID=America/Vancouver:20230623T170000
DTSTAMP:20260410T014722
CREATED:20230113T001015Z
LAST-MODIFIED:20230113T001015Z
UID:23312-1687248000-1687539600@scienceinboston.com
SUMMARY:FOCIS 2023
DESCRIPTION:FOCIS is THE meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and applying ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study. \nThrough the FOCIS Annual Meeting\, researchers and clinicians share knowledge across traditional disease borders\, and identify commonalities between treatments and therapies that are life changing for those affected with immune-mediated diseases. From the introduction of monoclonal antibodies in clinical practice — to recent advances in cancer immunotherapy – the past two decades have been transformational for patients living with immune-mediated diseases. \nFOCIS 2023 will take place\, in person\, June 20-23\, 2023\, at the Boston Marriott Copley Place. \nYour Health and Safety\nYour health and safety remain a top priority to FOCIS. The Annual Meeting will be held fully in person\, and we are committed to keeping you safe.
URL:https://scienceinboston.com/event/focis-2023/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230614T090000
DTEND;TZID=America/Vancouver:20230617T190000
DTSTAMP:20260410T014722
CREATED:20230327T025033Z
LAST-MODIFIED:20230327T025033Z
UID:24279-1686733200-1687028400@scienceinboston.com
SUMMARY:ISSCR 2023
DESCRIPTION:The world’s best and brightest in stem cell research and regenerative medicine convene once a year for the ISSCR Annual Meeting\, and you are invited! Join more than 4\,000 scientists from around the globe at ISSCR 2023 to take part in a 4-day program comprising the year’s most significant new advances in the field.
URL:https://scienceinboston.com/event/isscr-2023/
LOCATION:Boston Convention and Exhibition Center (BCEC)\, 415 Summer St.\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230613T190000
DTEND;TZID=America/Toronto:20230613T200000
DTSTAMP:20260410T014722
CREATED:20230511T170334Z
LAST-MODIFIED:20230511T170334Z
UID:24812-1686682800-1686686400@scienceinboston.com
SUMMARY:Public Symposium: Stem Cells at the Planetarium
DESCRIPTION:Join host Dr. Insoo Hyun at the Museum of Science’s renowned Charles Hayden Planetarium for a specially curated planetarium show\, followed by audience discussion with Dr. Arun Sharma. \nThe International Space Station (ISS) and Low Earth Orbit (LEO) can serve as accessible\, unique environments to study human development in microgravity. At the forefront of this new frontier is Dr. Sharma\, who led a project that sent human stem cell-derived heart cells to the ISS to study the effects of microgravity on human heart function. Learn how stem cell biomanufacturing in space is being explored through commercial\, governmental\, and academic collaboration.
URL:https://scienceinboston.com/event/public-symposium-stem-cells-at-the-planetarium/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230612T090000
DTEND;TZID=America/Vancouver:20230613T190000
DTSTAMP:20260410T014722
CREATED:20230604T193522Z
LAST-MODIFIED:20230604T193522Z
UID:25073-1686560400-1686682800@scienceinboston.com
SUMMARY:Boston Bacterial Meeting
DESCRIPTION:BBM was founded in 1995 by two postdocs from Richard Losick’s lab at Harvard\, Kit Pogliano and Karen McGovern\, with the goal of bringing bacteriologists from the greater Boston area together to present their work and share ideas. BBM\, now in its 29th year\, has proven to be a vibrant meeting\, attended not only by bacteriologists from the Boston area but from all over the country. Keeping with its roots\, the conference is being planned and organized by a committee of students\, postdocs\, and other early career researchers. This year\, the organizational committee is co-chaired by Alam García-Heredia\, a postdoc in Alan Grossman’s lab at MIT\, and Shailab Shrestha\, a graduate student in Aimee Shen’s lab at Tufts.
URL:https://scienceinboston.com/event/boston-bacterial-meeting/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230606T183000
DTEND;TZID=America/Toronto:20230606T220000
DTSTAMP:20260410T014722
CREATED:20230501T191828Z
LAST-MODIFIED:20230501T191828Z
UID:24686-1686076200-1686088800@scienceinboston.com
SUMMARY:Community Concert at BIO
DESCRIPTION:Celebrate the Massachusetts life sciences industry and the return of the BIO International Convention to Boston this June with a memorable night of music\, dancing\, and vibing. MassBio is pleased to welcome the artist/producer duo The Chainsmokers as headliners for the Massachusetts State of Possible Community Concert — an exclusive members-only\, free performance — on Tuesday\, June 6 at the premium music hall Big Night Live located near TD Garden. \nLight bites and drink tickets will be available. Doors will open at 6:30 PM with the entertainment kicking off at 8:00 PM. Tickets to the show will be available in the spring on a first-come\, first-served basis. To be the first to receive a link to reserve your seat(s)\, please express your interest today by filling out this form.
URL:https://scienceinboston.com/event/community-concert-at-bio/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230605T083000
DTEND;TZID=America/Toronto:20230605T103000
DTSTAMP:20260410T014722
CREATED:20230505T174322Z
LAST-MODIFIED:20230505T174322Z
UID:24714-1685953800-1685961000@scienceinboston.com
SUMMARY:Accelerate Access to EU Market: Biotech Valley in Wallonia (Belgium)
DESCRIPTION:Please join an exclusive Business Breakfast dedicated to Senior Executives of U.S. Biotech companies on how to accelerate access to the EU market. Wallonia/Belgium is a leading biotech hub for biomanufacturing and cell & gene therapy and offers a wide range of advantages for expanding your activities. Several distinguished and knowledgeable key speakers and Biotech representatives will be there so that you can streamline your investment approach such as Denis Dufrane M.D.\, Ph.D. Having transitioned from a researcher to the Co-founder\, CEO\, and CSO of Novadip Biosciences\, he will share his insights on how he successfully made the shift from the laboratory to creating a thriving biotech company within the Walloon Life Sciences ecosystem. \nThe seminar will take place on June 5th at 8:30am\, at Tufts Launchpad BioLabs\, just before the start of the BIO Convention. To attend\, please register via this link. \nFor any questions\, please feel free to contact Quentin Derzelle\, Trade Commissioner of the Wallonia Trade & Investment Agency in New York\, at newyork@awex-wallonia.com
URL:https://scienceinboston.com/event/accelerate-access-to-eu-market-biotech-valley-in-wallonia-belgium/
LOCATION:MA
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2023/05/https___cdn.evbuc_.com_images_493092679_1497539153743_1_original.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230514T140000
DTEND;TZID=America/Toronto:20230514T170000
DTSTAMP:20260410T014722
CREATED:20230501T191644Z
LAST-MODIFIED:20230501T191644Z
UID:24682-1684072800-1684083600@scienceinboston.com
SUMMARY:Life After Incubator: Finding Your Own Place and Meeting Your Vendor Matches
DESCRIPTION:What was once a crazy idea has turned into a full-fledged business with workers\, partners\, and investors. And as you’ve grown\, your comfy nook at the incubator has started to feel cramped. As you begin to envision a space to call your own\, the questions start to enter your head: Where do I start with moving? How do I lease lab space\, and how much do I need? How do I set up equipment and supplies accounts? What steps do I need to take to transition successfully? \nLet MassBio and some of our closest partners be your support team. A panel of CEOs and lab and facilities managers will answer your questions\, walk you through what the transition looks like\, and help you avoid common missteps. Our vendor showcase gives you a chance to meet the suppliers and to find your perfect match.
URL:https://scienceinboston.com/event/life-after-incubator-finding-your-own-place-and-meeting-your-vendor-matches/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230511T130000
DTEND;TZID=America/Toronto:20230511T140000
DTSTAMP:20260410T014722
CREATED:20230501T172812Z
LAST-MODIFIED:20230501T172812Z
UID:24665-1683810000-1683813600@scienceinboston.com
SUMMARY:Career Paths in Finance/Industry
DESCRIPTION:If you’re interested in career paths in finance/industry\, please join us for a conversation with Mani Foroohar about leveraging his scientific and medical expertise to transition into roles in Investment Banking! Mani is now a Senior Managing Director at SVB Securities but also co-founded Cellanyx which develops risk stratification models using live tumor cells to inform clinical treatment decisions. This discussion will be moderated by Christiana Bardon M.D.\, Co-Managing Partner of MPM | BioImpact Capital on Thursday\, May 11th from 1 – 2 PM (EST). Please RSVP using the following link: https://lnkd.in/eQPqepfn
URL:https://scienceinboston.com/event/career-paths-in-finance-industry/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2023/05/Harvard-Biotech-Club-Industry-101.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230504T183000
DTEND;TZID=America/Toronto:20230504T191500
DTSTAMP:20260410T014722
CREATED:20230419T161558Z
LAST-MODIFIED:20230419T161558Z
UID:24560-1683225000-1683227700@scienceinboston.com
SUMMARY:Moving Science from .edu to .com: A Revisit
DESCRIPTION:Vicki Sato\, PhD\, is a biologist\, immunologist\, and biotechnology executive with decades of experience leading teams in drug research and development. Molecules and therapeutics developed under her leadership have become critical treatments for HIV\, cystic fibrosis\, inflammation\, multiple sclerosis\, and Hepatitis C. \n\nFormer President and former Chief Science Officer of Vertex Pharmaceuticals\, one of the first biotechnology companies to exploit structure-based and computational chemistries in the design of new drugs.\nFormer Vice President of Research at Biogen\, leading research programs in the areas of inflammation\, thrombosis\, and HIV.\nFormer Professor of the Practice at Harvard University in Molecular and Cell Biology\, teaching the science of making medicines.\nFormer Professor at Harvard Business School where her work focused on productivity and innovation in biotechnology and pharmaceutical R&D.\nInaugural Co-Chair of the Advisory Council for the NYC LifeScience initiative for the Economic Development Corporation of the city of New York\, which is focused on driving economic growth and jobs by expanding the life science sector in the city.\nMember of the President’s Council of Advisors on Science and Technology (PCAST).\n\nAbout Whitehead Connects \nFeaturing prominent biotech\, pharma\, healthcare\, and venture capital leaders discussing the most important developments\, challenges\, and opportunities facing the biomedical science enterprise — the Whitehead Connects speaker series sparks dialogue and connection among members of the broader Whitehead Institute\, Massachusetts Institute of Technology\, Kendall Square\, and Boston bioscience communities. For more information about Whitehead Connects\, please contact Erin DeMarco at edemarco@wi.mit.edu.
URL:https://scienceinboston.com/event/moving-science-from-edu-to-com-a-revisit/
LOCATION:MA
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2023/04/WCN_Slide_2023_05_Sato_2x3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230502T180000
DTEND;TZID=America/Toronto:20230504T130000
DTSTAMP:20260410T014722
CREATED:20230501T191105Z
LAST-MODIFIED:20230501T191105Z
UID:24678-1683050400-1683205200@scienceinboston.com
SUMMARY:MIT Biology Catalyst Symposium
DESCRIPTION:In 2022\, the department\, with leadership from the Faculty DEI Committee and DEI Officer\, launched the MIT Biology Catalyst Symposium.  This symposium is part of a new effort to bring outstanding postdocs from traditionally underrepresented backgrounds in science to engage with members of our community. Aimed specifically at postdocs pursuing academic careers\, the three-day symposium provides a venue for participants to share their research\, discuss exciting new directions\, and make new professional connections. We will welcome eight Catalyst Fellows to campus for the first symposium in May of 2023.
URL:https://scienceinboston.com/event/mit-biology-catalyst-symposium/
LOCATION:MIT\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230429T090000
DTEND;TZID=America/Toronto:20230429T170000
DTSTAMP:20260410T014722
CREATED:20230307T230623Z
LAST-MODIFIED:20230307T230623Z
UID:23971-1682758800-1682787600@scienceinboston.com
SUMMARY:Microbial Sciences 20th Annual Symposium
DESCRIPTION:Since its inception in 2004\, MSI has sponsored and hosted an annual symposium for those in the Harvard and greater Boston communities. The spring event showcases magnificent research across a breadth of microbe-centric topics spanning environmental and biomedical sciences. Welcome to the microbial world!
URL:https://scienceinboston.com/event/microbial-sciences-20th-annual-symposium/
LOCATION:MA
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2023/03/MSI-Large.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230426T120000
DTEND;TZID=America/Toronto:20230426T133000
DTSTAMP:20260410T014723
CREATED:20221219T175510Z
LAST-MODIFIED:20221219T175510Z
UID:22980-1682510400-1682515800@scienceinboston.com
SUMMARY:Is It Possible to Bioprint Human Hearts?
DESCRIPTION:This interactive webinar series highlights notable researchers who are leading advances in biotechnology that could impact us all. Join the conversation and ask how biotechnology may affect society medically\, ethically\, and culturally. \nDr. Mark Skylar-Scott\, Department of Bioengineering at Stanford University \nHost:\nInsoo Hyun\, PhD\nDirector of the Center for Life Sciences and Public Learning\nMuseum of Science\, Boston \nAffiliate\nCenter for Bioethics\nHarvard Medical School
URL:https://scienceinboston.com/event/is-it-possible-to-bioprint-human-hearts/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230425T083000
DTEND;TZID=America/Toronto:20230425T200000
DTSTAMP:20260410T014723
CREATED:20230410T181707Z
LAST-MODIFIED:20230410T181707Z
UID:24439-1682411400-1682452800@scienceinboston.com
SUMMARY:2023 State of Possible Conference
DESCRIPTION:Each year\, MassBio’s State of Possible Conference celebrates the Massachusetts’ life sciences ecosystem\, giving attendees the opportunity to learn from experts\, hear from speakers\, participate in talks\, and expand their professional networks. “Being Bold. Looking Beyond” is this year’s theme with programming spotlighting the state’s global role in advancing science\, equity\, and patient-driven breakthroughs during a time of economic uncertainty. \nAnyone who is a part of the life sciences and biotech sectors in the region will find this year’s State of Possible agenda to be as diverse and dynamic as MassBio’s membership. Choose your own track\, science\, or business\, for a personalized experience and come together with the 500+ industry rockstars to hear about the state of the industry\, gain insights into health equity and oncology\, and discover why executives continue to choose Massachusetts. \nThe last two years have shown us the heights that the industry can reach and what it’s like to come back down to earth. Featuring a day of keynotes\, panel discussions\, a fireside chat\, and networking\, this year’s State of Possible promises to be the best one yet and an event not to be missed.
URL:https://scienceinboston.com/event/2023-state-of-possible-conference/
LOCATION:Royal Sonesta Boston\, 40 Edwin H Land Boulevard\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230420T170000
DTEND;TZID=America/Toronto:20230420T180000
DTSTAMP:20260410T014723
CREATED:20230403T172151Z
LAST-MODIFIED:20230403T172151Z
UID:24360-1682010000-1682013600@scienceinboston.com
SUMMARY:Biomedical Informatics Entrepreneurs Salon: Linda Avey
DESCRIPTION:Hosted by Harvard Office of Technology Development and the HMS Dept. of Biomedical Informatics. Open to all. \nLinda Avey reflects on her career journey and how the challenges she encountered in personalized health led to the founding of 23andMe and Precisely. From consumer genetics and the quantified self-movement to AI\, Linda will share her insights and vision for the future of a digital-first health system \nThis Entrepreneurs Salon will be hosted by Isaac Kohane\, Chair\, Department of Biomedical Informatics\, Harvard Medical School. \nLinda Avey is the co-founder and CEO of Austin-based Precisely (precise.ly)\, a digital assistant for automating routine medical flows and implementing personalized\, value-based care. \nIn 2006 Linda envisioned and co-founded 23andMe\, the leading consumer genetics research company (NASDAQ: ME). Her experience in the genetics research industry\, and its need for more participants\, led to her concept of the 23andMe research model\, which links genetic data to health information from the company’s millions of users. This is now fueling the discovery of potential drug targets and landing pharmaceutical partnerships valued in the hundreds of millions USD. \nLinda is on the advisory board of Alphabet’s life science subsidiary Verily and the Board of Fellows of Stanford Medical School. She was the founding independent board director at Rock Health\, the first venture fund dedicated to digital health\, where she advised startups ideating new ways of delivering healthcare.
URL:https://scienceinboston.com/event/biomedical-informatics-entrepreneurs-salon-linda-avey/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230419T120000
DTEND;TZID=America/Toronto:20230419T170000
DTSTAMP:20260410T014723
CREATED:20230403T172621Z
LAST-MODIFIED:20230403T172621Z
UID:24364-1681905600-1681923600@scienceinboston.com
SUMMARY:Cell and Gene Therapy Catapult Boston Showcase
DESCRIPTION:Join like-minded local senior executives in a discussion with Cell and Gene Therapy Catapult’s own senior executives by attending this showcase event. We will be exploring ways in which your organizations can leverage CGT Catapult’s years of manufacturing expertise\, facilities\, resources and broader capabilities around increasing value of your asset(s) to expedite your access to European and global markets. \nWe invite you to attend this in-person event at the MassBio Hub in Boston (19th of April at 12pm)\, to learn how the Cell and Gene Therapy Catapult provides enabling tools and expertise to US-based AT developers to de-risk and accelerate the AT manufacturing pathway and route to clinic. \nAttendees will gain knowledge in: \n\nHow you can leverage 10 years of experience of supporting multiple AT companies to licensure to enable you to evolve from a CGT developer to a CGT manufacturer\, with expedited timelines and minimal resources\nHow your organization can access the biggest CGT cluster outside of the US\nHow non-UK companies can access world-class AT clinical research and support in the UK. You will also get exposed to how policies are attracting foreign companies to set-up clinical trials and manufacture in the UK\, what resources and expertise are available to allow you to best leverage the UK healthcare system.\nHow the CGT Catapult can support you to easily navigate the regulatory pathways for ATs in UK and the European Union (EU).\nSome lessons learned from our CGT Catapult team on navigating requirements relevant to production of clinical material for USA\, EU and UK.\nSnippets of wisdom from CGT Catapult’s partners on do’s and don’ts for implementation of in-house manufacturing capabilities.\n\nAgenda \n– 12pm: Arrival and lunch \n– 12.15pm: Welcome and opening remarks \n– 12.20pm: CGT Catapult’s unique model to accelerate AT developers’ pathway to establish mature GMP manufacturing capability – Sharon Brownlow\, Chief Business Officer; Mark Fuller\, Managing Director Manufacturing: \n\nTurning therapy developers into experienced therapy manufacturers in partnership\nSuccesses that provided the hindsight for our new partners\n\n– 1pm: Access Strategy: AT regulatory pathway\, clinical trials in UK and routes to successful market access – Jacqueline Barry\, Chief Clinical Officer: \n\nSet up clinical trials in the UK with confidence\nAuthorization or authorisation; making best use of acceleration pathways in the UK and EU\n\n– 1.40pm Q&A \n– 2pm Close of lunchtime event \n– 2pm – 5pm Opportunity for companies to have 121’s with CGT Catapult \nOn the day there will also be an opportunity for 121’s with the CGT Catapult teams. Please contact John Kelly at john.kelly@ct.catapult.org.uk to arrange. These can be before or after the lunchtime event. We will also be available on Thursday 20th if a more comprehensive discussion is preferred. \nWho should attend: \n\nCGT developers considering establishing GMP manufacture for supply of clinical trial and marketed product globally\nCGT organizations seeking comprehensive assistance for set-up of clinical trials and to ease navigation of regulatory pathways in UK and/or EU for their ATs.\n\nWe have limited capacity for this event\, so we invite you to register at your earliest convenience. \nVenue accessibility can be found here\, please contact us for more information.
URL:https://scienceinboston.com/event/cell-and-gene-therapy-catapult-boston-showcase/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230406T170000
DTEND;TZID=America/Toronto:20230406T194500
DTSTAMP:20260410T014723
CREATED:20230317T160418Z
LAST-MODIFIED:20230317T160418Z
UID:24111-1680800400-1680810300@scienceinboston.com
SUMMARY:STEMCELL Technologies Career Open House
DESCRIPTION:After a busy day in the lab\, join us for beer\, wine\, and snacks at the annual STEMCELL Technologies Career Open House in Kendall Square. \nSpace is limited. Please RSVP by April 3 to reserve your spot!
URL:https://scienceinboston.com/event/stemcell-technologies-career-open-house/
LOCATION:MA
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2023/03/cambridge-career.jpg
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230406T120000
DTEND;TZID=America/Vancouver:20230406T130000
DTSTAMP:20260410T014723
CREATED:20230329T212536Z
LAST-MODIFIED:20230329T212536Z
UID:24324-1680782400-1680786000@scienceinboston.com
SUMMARY:Scientists in Solidarity: Negotiating Compensation
DESCRIPTION:As BIPOC scientists\, we often undervalue ourselves when it comes to compensation. Claim your fair share in your hard work! Join us at SIS to learn tactical skills and build confidence to prepare you for salary and benefits negotiation when you transition from academia to industry. Attendees of this informational session will also receive a list of resources to enhance financial literacy.
URL:https://scienceinboston.com/event/scientists-in-solidarity-negotiating-compensation/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2023/03/04.06.2023-Negotiating-Compensation.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230329T160000
DTEND;TZID=America/Toronto:20230329T170000
DTSTAMP:20260410T014723
CREATED:20230306T195624Z
LAST-MODIFIED:20230306T195624Z
UID:23945-1680105600-1680109200@scienceinboston.com
SUMMARY:How Small RNAs Regulate Genes - And Could Treat Disease
DESCRIPTION:In this webinar\, Whitehead Institute Member David Bartel will explore how microRNAs function and their role in health and disease. He’ll consider questions such as: How are microRNAs created and how have they evolved? How do microRNAs bind to – and repress the function of – messenger RNA sequences (mRNA). And\, what role does mRNA-repression play in normal development and in disease?
URL:https://scienceinboston.com/event/how-small-rnas-regulate-genes-and-could-treat-disease/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2023/03/WI_SciWebinar_slides_2023Mar_Bartel.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230328T083000
DTEND;TZID=America/Toronto:20230328T190000
DTSTAMP:20260410T014723
CREATED:20230327T052824Z
LAST-MODIFIED:20230327T052824Z
UID:24285-1679992200-1680030000@scienceinboston.com
SUMMARY:Pfizer Pharma Day 2023
DESCRIPTION:Our industry exists to bring life-changing breakthroughs to the patients who need them – a mission enhanced by collaboration. \nPfizer’s Pharma Day® 2023 provides an exciting opportunity for emerging innovators to be introduced to Pfizer Ignite – a new offering for biotech companies seeking a collaborative partner to help them advance the development of their ​​promising breakthrough therapies. \n\nPfizer Ignite works with innovative companies that are aligned with Pfizer’s priority therapeutic areas and are ready to move from candidate selection through Phase II. This offering provides support\, strategic input\, and end-to-end services including research\, development\, and manufacturing on a retained basis.\n\nPfizer’s Pharma Day® will provide attendees the opportunity to speak with Pfizer leaders about this innovative new offering\, as well as the chance to forge new relationships with biotech industry peers and colleagues. \nThis is a partnering event focused on science and innovation. No solicitations.
URL:https://scienceinboston.com/event/pfizer-pharma-day-2023/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
END:VCALENDAR